A Drug-Drug Interaction Study of Digoxin and PA21

NCT01477411 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Interaction Potentiation

Interventions

DRUG: PA21
DRUG: Digoxin

Sponsor

Vifor Pharma